Shire plc was a global pharmaceutical company that focused on the research, development, and commercialization of treatments for rare diseases and other specialty conditions. The company was founded in 1986 and was headquartered in Dublin, Ireland.
The stock ticker symbol for Shire plc was SHPG, and it was listed on the NASDAQ stock exchange. However, in 2019, the company was acquired by Takeda Pharmaceutical Company Limited, a Japanese multinational pharmaceutical company.
Following the acquisition, Shire plc became a wholly-owned subsidiary of Takeda, and the SHPG ticker symbol was retired. Takeda now trades on the New York Stock Exchange under the ticker symbol TAK.
Shire plc was a global pharmaceutical company that focused on the research, development, and commercialization of treatments for rare diseases and other specialty conditions. The company was founded in 1986 and was headquartered in Dublin, Ireland.